OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
This article was automatically collected from industry news feeds. Source: openai.com
Explore new OpenAI Academy learning paths for employees, developers, leaders, educators, a
Credit Saison’s ChatGPT Enterprise pilot delivered 954% ROI. See how leaders and employees
GPT‑6 is rolling out globally in ChatGPT with Intelligent UI, delivering faster responses
With GPT-5.6, GPT-6 Astra, and GPT‑Image‑2.5, Pollo AI helps creators turn bold ideas into
Build a multimodal RAG with Gemini Embedding 2: search text, images, PDFs, video, and audi
The new institute aims to surface differing views between Google, Google DeepMind, and the
